Ethosuximide | hsa00562 | Inositol phosphate metabolism | 4.28E-02 | 2 | Q14642, P19174 | INPP5A, PLCG1 | More | |
Ethosuximide | hsa04012 | ErbB signaling pathway | 4.28E-02 | 2 | Q13191, P19174 | CBLB, PLCG1 | More | |
Ethosuximide | hsa04213 | Longevity regulating pathway - multiple species | 8.73E-03 | 3 | Q9Y4H2, P11142, Q13547 | IRS2, HSPA8, HDAC1 | More | |
Ethosuximide | hsa04340 | Hedgehog signaling pathway | 2.62E-02 | 2 | O43791, P30279 | SPOP, CCND2 | More | |
Ethosuximide | hsa04612 | Antigen processing and presentation | 3.21E-02 | 3 | Q13241, P01732, P11142 | KLRD1, CD8A, HSPA8 | More | |
Ethosuximide | hsa04613 | Neutrophil extracellular trap formation | 1.31E-02 | 4 | P19174, P11215, Q13547, P62807 | PLCG1, ITGAM, HDAC1, HIST1H2BC | More | |
Ethosuximide | hsa04910 | Insulin signaling pathway | 1.67E-02 | 3 | Q14642, Q13191, Q9Y4H2 | INPP5A, CBLB, IRS2 | More | |
Ethosuximide | hsa05134 | Legionellosis | 3.60E-03 | 3 | P11215, P11142, P19875 | ITGAM, HSPA8, CXCL2 | More | |
Ethosuximide | hsa05203 | Viral carcinogenesis | 8.26E-03 | 4 | P30279, Q13547, Q15283, P62807 | CCND2, HDAC1, RASA2, HIST1H2BC | More | |
Ethosuximide | hsa05206 | MicroRNAs in cancer | 1.63E-02 | 4 | P30279, Q9Y4H2, Q13547, P19174 | CCND2, IRS2, HDAC1, PLCG1 | More | |